Oral delivery of diclofenac sodium using a novel solid-in-oil suspension

International Journal of Pharmaceutics

Volumn 313, Issue 1-2, 2006, Pages 159-162

  Piao, Hongyu ^a   Kamiya, Noriho ^a   Watanabe, Junji ^a   Yokoyama, Hideakira ^b   Hirata, Akihiko ^b   Fujii, Takeru ^b   Shimizu, Ichiro ^c   Ito, Susumu ^c   Goto, Masahiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b ASPION Corporation   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Diclofenac sodium; Gastric ulcer; NSAID; Oral administration; Solid in oil suspension

Indexed keywords

DICLOFENAC; SOYBEAN OIL;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; LD 50; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; RISK REDUCTION; SOYBEAN; SUSPENSION;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; EMULSIONS; HYDROGEN-ION CONCENTRATION; KINETICS; SOLUBILITY; SOYBEAN OIL; STOMACH ULCER;

EID: 33645313195     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.02.003     Document Type: Article

References (12)

1. A.A. Attama, I.T. Nzekwe, P.O. Nnamani, M.U. Adikwu, and C.O. Onugu The use of solid self-emulsifying systems in the delivery of diclofenac Int. J. Pharm. 262 2003 23 28
2. S.S. Biju, S. Saisivam, N.S. Maria, G. Rajan, and P.R. Mishra Dual coated erodible microcapsules for modified release of diclofenac sodium Eur. J. Pharm. Biopharm. 58 2004 61 67
3. Editorial Under surveillance Nat. Biotechnol. 23 2005 1
4. I.H. Kim, J.H. Park, I.W. Cheong, and J.H. Kim Swelling and drug release behavior of tablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles J. Control. Release 89 2003 225 233
5. M.D. Kurkuri, and T.M. Aminabhavi Poly (vinyl alcohol) and poly (acrylic acid) sequential interpenetrating network pH-sensitive microspheres for the delivery of diclofenac sodium to the intestine J. Control. Release 96 2004 9 20
6. E.C. Ku, J.M. Wasvary, and W.D. Cash Diclofenac sodium (GP 45840, Voltaren), apotent inhibitor of prostaglandin synthetase Biochem. Pharmacol. 24 1975 641 643
7. O. Ohmukai Lipo-NSAID preparation Adv. Drug Deliv. Rev. 20 1996 203 207
8. S.-Y. Okazaki, N. Kamiya, K. Abe, M. Goto, and F. Nakashio Novel preparation method for surfactant-lipase complexes utilizing water in oil emulsions Biotechnol. Bioeng. 55 1997 455 460
9. C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur. J. Pharm. Sci. 11 2000 s93 s98
10. C. Sakamoto NSAIDs caused gastric mcuosal injury: with a special reference to COX-2 J. Nippon Med. Sch. 70 2003 5 11
11. E. Toorisaka, H. Ono, K. Arimori, N. Kamiya, and M. Goto Hypoglycemic effect of surfactant-coated insulin solubilized in a novel solid-in-oil-in-water (S/O/W) emulsion Int. J. Pharm. 252 2003 271 274
12. T.D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J.A. Mitchell, and J.R. Vane Nonsteroid drug selectivities for cyclo-oxigenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointesitinal toxicity: a full in vitro analysis Proc. Natl. Acad. Sci. USA 96 1999 7563 7568